Rise and shine, everyone. Another day is on the way. This means, of course, that meetings and deadlines beckon. Never mind that a holiday weekend is just around the corner. To cope, we are brewing the mandatory cup of stimulation, and enjoying an unexpectedly cool breeze. So please join us as we peruse the news of the world. Good luck today and catch you soon...
AstraZeneca Loses Bid To Overturn Antitrust Fine (Dow Jones)
Biogen Names Exelisis' George Scangos As CEO (Bloomberg News)
Recession Hurts Funding For AIDS Drug Program (New York Times)
FDA Issues Latest List Of Drug With Possible Risks (Reuters)
Quebec To Cut Generic Drug Prices (PharmaTimes)
USPTO Denies Request To Re-Examine Plavix Patent (Dow Jones)
Michigan Grows CROs (Xconomy)
Calistoga Raises $40M To Fund Drug Trials (Seattles Times)
Alcon Sets Vote On Novartis Nominees (Wall Street Journal)
Class-Action Lawsuit Over Zyprexa Settled In Canada (Toronto Star)